Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Sotac Pharmaceuticals Ltd. Share Price
Day's Range
Day's Range
Low
₹95.10
High
₹95.10
Price Summary
| Previous Close | ₹95.10 |
|---|---|
| Day's Range | ₹95.10 - ₹95.10 |
| Open | ₹95.10 |
| 52 Week Range | ₹95.10 - ₹139.65 |
| Volume | 2,400 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 2.28 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.21 |
| Price/Earning (TTM) | 18.22 |
| TTM EPS (₹) | 5.22 |
| P/E Ratio | 16.35 |
| Book Value(₹) | 1.89 |
| PAT Margin (%) | 9.56 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 16.40 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 623.84 | 189.1 |
| Expenses | N/A | 0.0 |
| PBT | 64.14 | 16.86 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 47.72 | 12.05 |
About Sotac Pharmaceuticals Ltd.
| Founded | 2015 |
|---|---|
| Managing Director | Sharadkumar Dashrathbhai Patel |
| NSE Symbol | SOTAC |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,65,710.92 | 1,941.00 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,92,375.79 | 7,240.50 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,88,654.85 | 4,959.80 | 3,480.60 - 3,480.60 |
| Apollo Hospitals Enterprise Ltd. | 1,26,592.33 | 8,816.50 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,13,978.90 | 1,409.95 | 1,165.70 - 1,165.70 |
| Zydus Lifesciences Ltd. | 1,10,613.20 | 1,108.90 | 835.50 - 835.50 |
| Lupin Ltd. | 1,08,339.52 | 2,374.00 | 1,836.80 - 1,836.80 |
| Max Healthcare Institute Ltd. | 1,05,259.52 | 1,078.90 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 1,03,472.01 | 2,509.65 | 1,909.70 - 1,909.70 |
| Lenskart Solutions Ltd. | 96,638.09 | 557.45 | 0.00 - 0.00 |
No Records Found
Latest News
Gland Pharma informs about board meeting
Gland Pharma has informed that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026, inter alia, to consider and approve Unaudited Standalone and Consolidated Financial results of the Company for the quarter ended June 30, 2026.
The above information is a part of company’s filings submitted to BSE.
Lenskart Solutions informs about annual report
Lenskart Solutions has informed about the Annual Report of the Company for the Financial Year 2025-26, along with the Notice convening the 18th Annual General Meeting of the Company.
The above information is a part of company’s filings submitted to BSE.
Acutaas Chemicals - Quaterly Results
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 3224.09 | 2059.71 | 56.53 | 3224.09 | 2059.71 | 56.53 | 13237.92 | 9898.35 | 33.74 |
| Other Income | 44.76 | 160.20 | -72.06 | 44.76 | 160.20 | -72.06 | 458.78 | 183.36 | 150.21 |
| PBIDT | 1141.53 | 670.09 | 70.35 | 1141.53 | 670.09 | 70.35 | 5288.83 | 2434.78 | 117.22 |
| Interest | 11.18 | 6.20 | 80.32 | 11.18 | 6.20 | 80.32 | 30.77 | 58.57 | -47.46 |
| PBDT | 1130.35 | 663.89 | 70.26 | 1130.35 | 663.89 | 70.26 | 5258.06 | 2376.21 | 121.28 |
| Depreciation | 90.20 | 74.62 | 20.88 | 90.20 | 74.62 | 20.88 | 330.32 | 240.45 | 37.38 |
| PBT | 1040.15 | 589.27 | 76.52 | 1040.15 | 589.27 | 76.52 | 4927.74 | 2135.76 | 130.73 |
| TAX | 281.19 | 142.81 | 96.90 | 281.19 | 142.81 | 96.90 | 1265.99 | 540.29 | 134.32 |
| Deferred Tax | 25.87 | 15.53 | 66.58 | 25.87 | 15.53 | 66.58 | 111.09 | 70.58 | 57.40 |
| PAT | 758.96 | 446.46 | 70.00 | 758.96 | 446.46 | 70.00 | 3661.75 | 1595.47 | 129.51 |
| Equity | 409.36 | 409.34 | 0.00 | 409.36 | 409.34 | 0.00 | 409.36 | 409.34 | 0.00 |
| PBIDTM(%) | 35.41 | 32.53 | 8.83 | 35.41 | 32.53 | 8.83 | 39.95 | 24.60 | 62.42 |
Dr. Lal Pathlabs - Quaterly Results
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 7644.00 | 6407.00 | 19.31 | 7644.00 | 6407.00 | 19.31 | 26476.00 | 23516.00 | 12.59 |
| Other Income | 299.00 | 263.00 | 13.69 | 299.00 | 263.00 | 13.69 | 1127.00 | 1115.00 | 1.08 |
| PBIDT | 2684.00 | 2097.00 | 27.99 | 2684.00 | 2097.00 | 27.99 | 8664.00 | 7770.00 | 11.51 |
| Interest | 61.00 | 45.00 | 35.56 | 61.00 | 45.00 | 35.56 | 220.00 | 215.00 | 2.33 |
| PBDT | 2623.00 | 2052.00 | 27.83 | 2623.00 | 2052.00 | 27.83 | 8143.00 | 7555.00 | 7.78 |
| Depreciation | 400.00 | 328.00 | 21.95 | 400.00 | 328.00 | 21.95 | 1541.00 | 1342.00 | 14.83 |
| PBT | 2223.00 | 1724.00 | 28.94 | 2223.00 | 1724.00 | 28.94 | 6602.00 | 6213.00 | 6.26 |
| TAX | 564.00 | 431.00 | 30.86 | 564.00 | 431.00 | 30.86 | 1520.00 | 1240.00 | 22.58 |
| Deferred Tax | -9.00 | 22.00 | -140.91 | -9.00 | 22.00 | -140.91 | 14.00 | -393.00 | -103.56 |
| PAT | 1659.00 | 1293.00 | 28.31 | 1659.00 | 1293.00 | 28.31 | 5082.00 | 4973.00 | 2.19 |
| Equity | 1676.00 | 838.00 | 100.00 | 1676.00 | 838.00 | 100.00 | 1676.00 | 836.00 | 100.48 |
| PBIDTM(%) | 35.11 | 32.73 | 7.28 | 35.11 | 32.73 | 7.28 | 32.72 | 33.04 | -0.96 |
Onesource Specialty - Quaterly Results
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 4464.71 | 3210.12 | 39.08 | 4464.71 | 3210.12 | 39.08 | 14053.81 | 12995.89 | 8.14 |
| Other Income | 37.87 | 52.55 | -27.94 | 37.87 | 52.55 | -27.94 | 150.08 | 176.82 | -15.12 |
| PBIDT | 1179.19 | 851.30 | 38.52 | 1179.19 | 851.30 | 38.52 | 2840.01 | 3869.57 | -26.61 |
| Interest | 305.17 | 270.31 | 12.90 | 305.17 | 270.31 | 12.90 | 1205.76 | 1616.50 | -25.41 |
| PBDT | 874.02 | 580.99 | 50.44 | 874.02 | 580.99 | 50.44 | 1580.05 | 1130.57 | 39.76 |
| Depreciation | 361.77 | 332.84 | 8.69 | 361.77 | 332.84 | 8.69 | 1367.95 | 1345.12 | 1.70 |
| PBT | 512.25 | 248.15 | 106.43 | 512.25 | 248.15 | 106.43 | 212.10 | -214.55 | -198.86 |
| TAX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -414.55 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -414.55 | 0.00 |
| PAT | 512.25 | 248.15 | 106.43 | 512.25 | 248.15 | 106.43 | 212.10 | 200.00 | 6.05 |
| Equity | 114.64 | 114.46 | 0.16 | 114.64 | 114.46 | 0.16 | 114.62 | 114.43 | 0.17 |
| PBIDTM(%) | 26.41 | 26.52 | -0.41 | 26.41 | 26.52 | -0.41 | 20.21 | 29.78 | -32.13 |
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Sotac Pharmaceuticals Ltd. is ₹95.10 as of 2026-07-15.
The market capitalisation of Sotac Pharmaceuticals Ltd. is ₹105.09 as of 2026-07-15.
The 1-year return of Sotac Pharmaceuticals Ltd. is -29.90% as of 2026-07-15.
The P/E ratio of Sotac Pharmaceuticals Ltd. is 16.35 as of 2026-07-25.
The 52-week high and low of Sotac Pharmaceuticals Ltd. are ₹139.65 and ₹95.10, respectively, as of 2026-07-15.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
